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the inflammatory pathway 2. Further studies
have deduced that the function of HA is depen-
dent on its size, but the question remains con-
troversial. Some authors state that HA frag-
ments smaller than 500 kDa induces inflamma-
tory responses, whereas larger MW HA mixtu-
res are anti-inflammatory and anti-angiogenic 3.
Substantial evidence from other authors indica-
tes that, in sites of cutaneous inflammation, HA,
may be depolymerized in small fragments
(MW < 200 kDa) that stimulates immunocom-
petent cells, including keratinocytes, to produ-
ce different soluble factors with antibacterial
activity and to revert LPS-induced pro-inflam-
matory mediators 4. Fidia Farmaceutici S.p.A.
produced a small fragment HA (MW: 68 kDa)
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Hyaluronic acid (HA) is a linear non-sulphated glycosaminoglycan, used in dermatology as a
biomaterial for bioengineering purposes, temporary dermal filler, stimulation of wound hea-
ling as well as drug vehicle in topical formulations. In addition to the well-characterized
structural properties, extensive research on HA has revealed a range of vastly immune-
modulatory effects, dependent on its size. In this in vitro study we investigated the ability of
HA-S3, a small fragment HA (MW, molecular weight: 68 kDa) with degree of sulphatation
of 3 and of HA fraction (MW:210 kDa) to reduce the bacterial induced inflammatory respon-
se in spontaneous immortalized keratinocytes. To this purpose, HaCaT cells were treated for
24 hours with 25 µg/ml of E. Coli derived bacterial lipopolysaccharide (LPS) in absence or
presence of small fragment HA-S3 or HA. Cell viability was thereafter assessed using trypan
blue stain and interleukin (IL)-8, IL-1β and tumor necrosis factor alpha (TNF-α) concentra-
tions were determined in cell supernatants by single enzyme-linked immunoadsorbent assay
(ELISA). Our results showed that  cell viability was not affected either by HA-S3 or HA which
in turn were able to reduce LPS-induced mortality. HA and especially HA-S3 were able to
significantly reduce LPS-induced pro-inflammatory cytokines. Our observation might sugge-
st new perspectives in the development of HA-S3 containing topical products able to modula-
te cutaneous inflammatory response.
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Hyaluronic acid (HA) is a linear non-sulphated
glycosaminoglycan, composed of glucuronic
acid and N-acetylglucosamine disaccharide
units, abundant in the form of a high-molecular-
weight (HMW) polymer ranging from 105 to 107
Da.1 HA is able to bind water, building a peri-
cellular coat, which, in turn, supports volume
expansion and diffusion of metabolites. HA is
nowadays used in dermatology as a biomaterial
for bioengineering purposes, temporary dermal
filler, stimulation of wound healing as well as
drug vehicle in topical formulations 1. In addi-
tion to the well-characterized structural proper-
ties, extensive research on HA has revealed a
range of vastly immune-modulatory effects,
focused on the regulatory influence exerted on
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with degree of sulphatation of 3 (HA-S3) and a
HA fraction (MW:210 kDa). In this in vitro
study we investigated the ability of HA-S3 and
HA to reduce the bacterial induced inflamma-
tory response in spontaneous immortalized
keratinocytes. To this purpose, HaCaT cells
were treated for 24 hours with 25 µg/ml of E.
Coli derived bacterial endotoxin-lipopolysac-
charide (LPS, Sigma-Aldrich, Oakville, ON,
Canada) in absence or presence of small frag-
ment HA-S3 or HA (1 mg/ml, Fidia Farmaceutici,
Abano Terme, PD, Italy) (Figure 1). 
Cell viability was thereafter assessed using try-
pan blue stain and interleukin (IL)-8, IL-1β and
tumor necrosis factor alpha (TNF-α) concentra-
tions were determined in cell supernatants by
single enzyme-linked immunoadsorbent assay
(ELISA) (Figure 2) using commercially availa-
Figure 1.
Study design. Schematic representation of the experimental setting with LPS (25 µg/ml) stimulation 
and HA or HA-S3 (1 mg/ml) treatment.
Figure 2.
Cell viability and protein assessment. (a) Evaluation of cell viability in HaCaT cells stimulated or not with LPS (25 µg/mL)
and incubated with HA or HA-S3  (1 mg/ml). Cell viability was measured at 24 h. Statistical significance was determi-
ned with respect to the viability of non-stimulated cells. (b) IL-8, IL-1β and TNF-α protein levels in supernatants from
HaCaT cells stimulated or not with LPS (25 µg /mL) and incubated with HA or HA-S3  (1 mg/ml) at 24h. All statistical
analyses were performed using GraphPad Prism 4.0 (GraphPad Software Inc., La Jolla, CA). Data that passed the nor-
mality test were analysed with two tailed t-test. Values of p < 0.05 were considered significant. Data are expressed as
means ± SD of three independent experiments, each performed in triplicate (*p < 0.05, **p < 0.01 ).
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ble kit (R&D Systems, Minneapolis, MN, USA),
according to the manufacturer’s instructions.
Our results demonstrated that HA-S3 or HA
did not exert any toxic effect but both com-
pounds were protective toward LPS-induce
HaCaT cell damage. In particular, cell viability
was not affected either by HA-S3 or HA which
in turn were able to reduce LPS-induced mor-
tality, increasing cell viability rate from 76% to
93 and 95% respectively (Figure 2a). 
Concerning the inflammatory modulators
assessed, LPS as expected 5, considerably
enhanced protein levels of IL-8 and IL-1β in
cell supernatants (p < 0.05). HA (p < 0.05) and
especially HA-S3 (p < 0.01) were able to signi-
ficantly reduce LPS-induced pro-inflammatory
cytokines. A similar trend was found also for
TNF-α (Figure 2b) which was slightly enhan-
ced after LPS compared to control. Our data
corroborates the findings of Gariboldi et al. who
demonstrated that HA was able to revert to
basal level, the increase of the same pro-inflam-
matory mediators induced by LPS in kerati-
nocytes 4. 
In our study a step forward has been made,
resulting small fragment HA-S3 more effective
than small HA. Our observation might suggest
new perspectives in the development of HA-S3
containing topical products able to modulate
cutaneous inflammatory response.
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